Role of HLA in hematopoietic SCT

[1]  J. Nowak,et al.  Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. , 2008, Tissue antigens.

[2]  E. Mejstrikova,et al.  Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen‐mismatched unrelated donors , 2008, Pediatric transplantation.

[3]  G. Salles,et al.  Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. , 2007, Tissue antigens.

[4]  Shunichi Kato,et al.  High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. , 2007, Blood.

[5]  M. Labopin,et al.  Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation , 2007, Bone Marrow Transplantation.

[6]  Y. Lau,et al.  Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[7]  A. Gratwohl,et al.  The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable , 2007, Bone Marrow Transplantation.

[8]  D. Roelen,et al.  Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[9]  X. Yang,et al.  Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant , 2007, Bone Marrow Transplantation.

[10]  E. Shpall,et al.  Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies , 2007, Bone Marrow Transplantation.

[11]  M. Gobbi,et al.  Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant , 2007, Bone Marrow Transplantation.

[12]  J. Mehta,et al.  Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation , 2007, Bone Marrow Transplantation.

[13]  H. Heslop,et al.  Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[14]  J. Nowak,et al.  Efficacy of bone marrow donor searches performed by Institute of Haematology and Blood Transfusion in domestic and foreign registries in 2001-2006 for the patients with acute and chronic leukemia , 2007 .

[15]  Harriet Noreen,et al.  Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. , 2007, Human immunology.

[16]  M. Malkki,et al.  Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. , 2007, Tissue antigens.

[17]  M. Horowitz,et al.  Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. , 2007, Tissue antigens.

[18]  J. Ritz,et al.  Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[19]  J. Bourhis,et al.  Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.

[21]  Z. Estrov,et al.  Hematological Malignancies , 2004, Hematology.

[22]  C. Craddock,et al.  The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. , 2004, Blood.

[23]  R. Handgretinger,et al.  T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation , 2003, British journal of haematology.

[24]  Franco Locatelli,et al.  Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.

[25]  C. Schmoor,et al.  Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Derek Middleton,et al.  A new allele frequency database , 2002 .

[27]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[28]  G. Church,et al.  A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression , 2000, Nature Genetics.

[29]  A. Tichelli,et al.  Recent improvement in outcome of unrelated donor transplantation for aplastic anemia , 2008, Bone Marrow Transplantation.

[30]  A. Begovich,et al.  A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. , 2007, Human immunology.

[31]  H. Greinix,et al.  Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors , 2005, Bone Marrow Transplantation.

[32]  D Middleton,et al.  New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.

[33]  M. Sykes.  Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors , 2022 .